DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,115 filers reported holding DANAHER CORPORATION in Q3 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,812 | -0.7% | 31,489 | -4.0% | 0.12% | -3.2% |
Q2 2023 | $7,871 | -5.1% | 32,796 | -0.3% | 0.12% | -12.6% |
Q1 2023 | $8,293 | -99.9% | 32,905 | -1.3% | 0.14% | -8.9% |
Q4 2022 | $8,853,000 | -99.9% | 33,353 | -1.3% | 0.16% | -9.8% |
Q3 2022 | $8,732,000,000 | +103815.3% | 33,806 | +2.0% | 0.17% | +6.7% |
Q2 2022 | $8,403,000 | -11.4% | 33,146 | +2.5% | 0.16% | -1.8% |
Q1 2022 | $9,487,000 | -99.9% | 32,342 | +0.9% | 0.17% | -10.8% |
Q4 2021 | $10,547,000,000 | +115775.6% | 32,057 | +7.2% | 0.19% | +1.6% |
Q3 2021 | $9,102,000 | +19.6% | 29,899 | +5.4% | 0.18% | +13.0% |
Q2 2021 | $7,612,000 | +28.9% | 28,366 | +8.1% | 0.16% | +13.3% |
Q1 2021 | $5,907,000 | +6.2% | 26,243 | +4.8% | 0.14% | -7.1% |
Q4 2020 | $5,561,000 | +13.4% | 25,034 | +9.9% | 0.15% | -6.1% |
Q3 2020 | $4,904,000 | +33.0% | 22,776 | +9.3% | 0.16% | +17.1% |
Q2 2020 | $3,686,000 | +50.5% | 20,847 | +30.6% | 0.14% | +38.6% |
Q4 2019 | $2,449,000 | +10.4% | 15,957 | +3.9% | 0.10% | -3.8% |
Q3 2019 | $2,218,000 | +24.5% | 15,357 | +13.6% | 0.10% | +7.1% |
Q1 2019 | $1,781,000 | +163.5% | 13,514 | +68.1% | 0.10% | +32.4% |
Q2 2017 | $676,000 | – | 8,041 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 241,441 | $70,822,000 | 14.94% |
Defender Capital, LLC. | 143,752 | $42,381,000 | 14.74% |
Third Point | 2,490,000 | $730,392,000 | 9.51% |
Riverstone Advisors, LLC | 63,015 | $18,484,000 | 9.49% |
11 Capital Partners LP | 96,063 | $28,178,000 | 8.99% |
Eos Focused Equity Management, L.P. | 34,026 | $9,981,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 187,609 | $55,031,000 | 7.01% |
Mirova US LLC | 1,242,440 | $364,444,000 | 7.00% |
Front Street Capital Management, Inc. | 118,397 | $34,729,000 | 6.47% |
Alphinity Investment Management Pty Ltd | 909,181 | $266,690,000 | 6.21% |